Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
Carrie E Robertson, Ivan GarzaDepartment of Neurology, Mayo Clinic, Rochester, MN, USAAbstract: OnabotulinumtoxinA, a neurotoxin, has been studied in numerous trials as a novel preventive therapy for migraine headache. The data would support that it may be effective at reducing headache days in pati...
Guardado en:
Autores principales: | Robertson CE, Garza I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d61c8e60befc41f7829af236dcaf6094 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
por: Stefan Evers
Publicado: (2007) -
Neurologic uses of botulinum neurotoxin type A
por: John P Ney, et al.
Publicado: (2007) -
Management of migraine in adolescents
por: Marielle A Kabbouche, et al.
Publicado: (2008) -
Almotriptan in the treatment of migraine
por: Giorgio Sandrini, et al.
Publicado: (2007) -
Review of frovatriptan in the treatment of migraine
por: Leslie Kelman
Publicado: (2008)